This molded glass furnace refurbishment completes the revamping project of the entire plant initiated in 2019. The new equipment allows an increase in the glass melting power, thus improving the quality of the final product. Thanks to a proprietary this furnace ensures ideal glass distribution, as well as the production of both transparent and amber type I glass bottles, responding in a more effective way to the increased demand for glass vials used for complex drug formulations such as vaccines and several life-saving medicines.
The flexibility on the control of the energy consumption and the real-time monitoring emissions will also reduce the environmental impact of the plant anticipating the new EU sustainability protection policies.
"Thanks to these new investments, we have consistently increased our industrial capacity on glass pharma packaging production, whilst strengthening our capability to provide a complete packaging solution for injectable drugs," commented Andrea Lodetti, CEO at Bormioli Pharma. "We are proud to be able to support more and better our partners in the pharma industry, helping to bring essential drugs and therapies where they’re needed the most, especially during these challenging times.”